Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Translational Biomarkers, Infectious Diseases Therapeutic Area, Janssen Pharmaceutica NV, Beerse, Belgium.
J Infect Dis. 2022 Aug 12;226(Suppl 1):S45-S54. doi: 10.1093/infdis/jiac163.
Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and young children worldwide. Here we evaluated host demographic and viral factors associated with RSV disease severity in 325 RSV-infected infants under 1 year of age from 3 European countries during 2017-2020. Younger infants had a higher clinical severity (ReSViNET) score and were more likely to require hospitalization, intensive care, respiratory support, and/or mechanical ventilation than older infants (<3 months vs 3 to <6 months and 3 to <6 months vs ≥6 months). Older age (≥6 months vs <3 months), higher viral load, and RSV-A were associated with a greater probability of fever. RSV-A and RSV-B caused similar disease severity and had similar viral dynamics. Infants with a more severe RSV infection, demonstrated by having a higher ReSViNET score, fever, and requiring hospitalization and intensive care, were more likely to have developed subsequent wheezing at 1 year of age.
NCT03756766.
呼吸道合胞病毒(RSV)在全球范围内导致婴儿和幼儿发病率和死亡率较高。在这里,我们评估了宿主人口统计学和病毒因素与 2017 年至 2020 年期间来自 3 个欧洲国家的 325 名 1 岁以下 RSV 感染婴儿的 RSV 疾病严重程度相关。年龄较小的婴儿临床严重程度(ReSViNET)评分更高,更有可能需要住院、重症监护、呼吸支持和/或机械通气,而年龄较大的婴儿(<3 个月比 3 至<6 个月和 3 至<6 个月比≥6 个月)。年龄较大(≥6 个月比<3 个月)、病毒载量较高和 RSV-A 与发烧的可能性更大相关。RSV-A 和 RSV-B 引起的疾病严重程度相似,病毒动力学也相似。具有更高 ReSViNET 评分、发烧和需要住院和重症监护的更严重 RSV 感染的婴儿,在 1 岁时更有可能发展为随后的喘息。
NCT03756766。